Evidence map›Paper›PMID 38947487›Full record

ArticleHeliyon2024

Exserolide J ameliorates lipid accumulation

Yan Zhang, Xue Wang, Tian Liu, Zi-Yi Zhang, Wen-Gang Song, Shou-Dong Guo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Effects ofMetabolites · 2024
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yan ZhangDepartment of Endocrinology and Metabolism, Guiqian International General Hospital, Guiyang, 550018, China.
Xue WangInstitute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China.
Tian LiuInstitute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China.
Zi-Yi ZhangSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001, China.
Wen-Gang SongShandong Provincial Key Laboratory for Rheumatic Disease and Translational Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China.
Shou-Dong GuoInstitute of Lipid Metabolism and Atherosclerosis, Innovative Drug Research Centre, School of Pharmacy, Shandong Second Medical University, Weifang, 261053, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exserolides are isocoumarin derivatives containing lactone moiety. Recently, some isocoumarins have been demonstrated to ameliorate hyperlipidemia, a major factor for inducing cardiovascular diseases. However, the effects and mechanisms of action of exserolides on hyperlipidemia are not known. The aim of this study is to investigate whether the marine fungus

Indexed as

Foam cellIsotope tracingLXRα agonistMolecule dockingPPARα agonist

Identifiers

PMID38947487
PMCPMC11214467

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.